The Brief
What Cleerly Heart AI does and why it matters
Cleerly provides FDA-cleared AI analysis of coronary CT angiography that quantifies plaque and stenosis for precise heart disease assessment. Cardiologists get detailed disease characterization beyond traditional calcium scoring.
Builder’s Brief
Cleerly Heart AI is a healthcare tool on Falcoscan. AI coronary artery disease analysis from CT scans. Falcoscan rates Cleerly Heart AI with an Opportunity score of 86/100, a Saturation score of 6/100, and a Wrapper-risk score of 5/100. Market signal: hot. Cleerly Heart AI is founded in 2017, currently at Series_a stage. Pricing: Paid. Rating 4.7/5 across 2 tracked views.